Hand dermatitis in adults referred for patch testing: Analysis of North American Contact Dermatitis Group Data, 2000 to 2016.


Journal

Journal of the American Academy of Dermatology
ISSN: 1097-6787
Titre abrégé: J Am Acad Dermatol
Pays: United States
ID NLM: 7907132

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 26 10 2020
revised: 16 11 2020
accepted: 19 11 2020
pubmed: 2 12 2020
medline: 26 8 2021
entrez: 1 12 2020
Statut: ppublish

Résumé

Hand eczema (HE) is a heterogeneous and burdensome disorder. To characterize the clinical characteristics, etiologies and allergen relevance in adults with HE referred for patch testing. Retrospective analysis (2000-2016) of North American Contact Dermatitis Group data (n = 37,113). Overall, 10,034 patients had HE, with differences of overlap between allergic contact, irritant contact, and atopic dermatitis. Allergic contact HE fluctuated, whereas atopic HE steadily increased, and irritant HE decreased over time. HE was associated with higher proportions of positive patch tests (67.5% vs 63.8%; χ No data on HE phenotype. HE in adults was associated with higher proportions of positive patch tests, with a heterogeneous profile of allergens. Patch testing remains an important tool in the evaluation of patients with HE.

Sections du résumé

BACKGROUND BACKGROUND
Hand eczema (HE) is a heterogeneous and burdensome disorder.
OBJECTIVE OBJECTIVE
To characterize the clinical characteristics, etiologies and allergen relevance in adults with HE referred for patch testing.
METHODS METHODS
Retrospective analysis (2000-2016) of North American Contact Dermatitis Group data (n = 37,113).
RESULTS RESULTS
Overall, 10,034 patients had HE, with differences of overlap between allergic contact, irritant contact, and atopic dermatitis. Allergic contact HE fluctuated, whereas atopic HE steadily increased, and irritant HE decreased over time. HE was associated with higher proportions of positive patch tests (67.5% vs 63.8%; χ
LIMITATIONS CONCLUSIONS
No data on HE phenotype.
CONCLUSION CONCLUSIONS
HE in adults was associated with higher proportions of positive patch tests, with a heterogeneous profile of allergens. Patch testing remains an important tool in the evaluation of patients with HE.

Identifiants

pubmed: 33259878
pii: S0190-9622(20)33103-0
doi: 10.1016/j.jaad.2020.11.054
pii:
doi:

Substances chimiques

Allergens 0
Irritants 0
Metals 0
Preservatives, Pharmaceutical 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

989-999

Informations de copyright

Copyright © 2020 American Academy of Dermatology, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest None disclosed.

Auteurs

Jonathan I Silverberg (JI)

Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC; Department of Dermatology, the Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: jonathanisilverberg@gmail.com.

Erin M Warshaw (EM)

Department of Dermatology, Park Nicollet Health Services, Minneapolis, Minnesota; Department of Dermatology, University of Minnesota, Minneapolis, Minnesota; Department of Dermatology, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota.

Amber R Atwater (AR)

Department of Dermatology, Duke University Medical Center, Durham, North Carolina.

Howard I Maibach (HI)

Department of Dermatology, University of California San Francisco, San Francisco, California.

Kathryn A Zug (KA)

Department of Dermatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.

Margo J Reeder (MJ)

Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.

Denis Sasseville (D)

Division of Dermatology, Montreal General Hospital, McGill University, Montreal, Canada.

James S Taylor (JS)

Department of Dermatology, Cleveland Clinic, Cleveland, Ohio.

Joseph F Fowler (JF)

Division of Dermatology University of Louisville, Louisville, Kentucky.

Melanie D Pratt (MD)

Division of Dermatology, University of Ottawa, Ottawa, Canada.

Anthony F Fransway (AF)

Associates in Dermatology, Fort Myers, Florida.

Matthew J Zirwas (MJ)

Department of Dermatology, Ohio State University, Columbus, Ohio.

Donald V Belsito (DV)

Department of Dermatology, Columbia University, New York, New York.

James G Marks (JG)

Department of Dermatology, Pennsylvania State University, State College, Pennsylvania.

Vincent A DeLeo (VA)

Department of Dermatology, Keck School of Medicine, Los Angeles, California.

Joel G DeKoven (JG)

Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH